Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 14.00M
March 31, 2026 18.44M
December 31, 2025 23.23M
September 30, 2025 10.57M
June 30, 2025 14.75M
March 31, 2025 17.84M
December 31, 2024 5.952M
September 30, 2024 4.576M
June 30, 2024 7.993M
March 31, 2024 11.73M
December 31, 2023 5.583M
September 30, 2023 2.605M
June 30, 2023 7.118M
March 31, 2023 10.24M
Date Value
December 31, 2022 13.18M
September 30, 2022 17.85M
June 30, 2022 25.25M
March 31, 2022 31.41M
December 31, 2021 32.17M
September 30, 2021 11.94M
June 30, 2021 18.80M
March 31, 2021 26.96M
December 31, 2020 5.834M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 9.559M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc 203.13M
Cellectis SA 166.85M
Akari Therapeutics Plc 7.754M
DBV Technologies SA --
argenx SE --